Efficacy and safety of the single-dose pegylated G-CSF vs. daily G-CSF for peripheral blood stem cells mobilization in donors: a multicenter, randomized controlled trial - Top-Institutions - MDSpire

Efficacy and safety of the single-dose pegylated G-CSF vs. daily G-CSF for peripheral blood stem cells mobilization in donors: a multicenter, randomized controlled trial

  • By

  • Jiali Li

  • Sha Zhou

  • Xiaoping Li

  • Xiangyu Ma

  • Sanbin Wang

  • Yicheng Zhang

  • Shifeng Lou

  • Jun Rao

  • Ping Wang

  • Lidan Zhu

  • Ting Chen

  • Xixi Xiang

  • Shichun Gao

  • Han Yao

  • Peiyan Kong

  • Lei Gao

  • Cheng Zhang

  • Xi Zhang

  • Li Gao

  • June 24, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Hamburg Hospital
    Hamburg Hospital

    Hamburg, Germany

    Key Differentiators

    • Hematology
  • #2

    University Clinic of Rostock
    University Clinic of Rostock

    Rostock, Germany

    Key Differentiators

    • Hematology
  • #3

    Stanford University
    Stanford University

    Stanford, California

    Key Differentiators

    • Hematology
  • #4

    University Hospital of Bern
    University Hospital of Bern

    Bern, Switzerland

    Key Differentiators

    • Hematology
  • #5

    French medical centers
    French medical centers

    France, France

    Key Differentiators

    • Hematology

Original Source(s)

Related Content